Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Campylobacter-triggered reactive arthritis: a population-based study.

T Hannu1, L Mattila, H Rautelin

  • 1Department of Medicine, Division of Rheumatology, Helsinki University Central Hospital, Finland.

Rheumatology (Oxford, England)
|April 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Signalling profile of circulating leucocytes of subjects with Raynaud's phenomenon in relation to systemic sclerosis: a pilot study.

Scandinavian journal of rheumatology·2025
Same author

Limited reduction of bone mineral density in patients with early rheumatoid arthritis receiving aggressive treatment: 10 year results of the NEO-RACo study.

Scandinavian journal of rheumatology·2025
Same author

The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis.

Arthritis research & therapy·2022
Same author

Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.

Rheumatology international·2021
Same author

Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab.

Scandinavian journal of rheumatology·2021
Same author

Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis.

Scandinavian journal of rheumatology·2021
Same journal

The prevalence and incidence of Raynaud's in England, United Kingdom.

Rheumatology (Oxford, England)·2026
Same journal

Pediatric macrophage activation syndrome: clinical features and outcomes across diverse etiologies.

Rheumatology (Oxford, England)·2026
Same journal

Vaccination coverage of influenza and pneumococcal vaccines in patients with rheumatic diseases: a systematic review and meta-analysis.

Rheumatology (Oxford, England)·2026
Same journal

Comment on: Distinct cytokine and cytokine receptor expression patterns characterise different forms of myositis.

Rheumatology (Oxford, England)·2026
Same journal

A Delphi survey of patients and clinicians on a unified and stratified approach to managing GCA-PMR spectrum disease.

Rheumatology (Oxford, England)·2026
Same journal

Cardiac involvement in Behçet's syndrome: findings from a clinically driven cardiological evaluation.

Rheumatology (Oxford, England)·2026
See all related articles

Reactive arthritis (ReA) is a common consequence of Campylobacter infection, affecting adults more frequently. This study found an annual incidence of 4.3 per 100,000, with mild symptoms in most cases.

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Epidemiology

Background:

  • Campylobacter infections are common causes of gastroenteritis.
  • Reactive arthritis (ReA) is a known extraintestinal manifestation of bacterial infections.
  • The precise incidence and clinical spectrum of Campylobacter-associated ReA in the general population require further elucidation.

Purpose of the Study:

  • To determine the incidence of Campylobacter-associated reactive arthritis (ReA) and other reactive musculoskeletal conditions.
  • To describe the clinical characteristics of ReA following Campylobacter infection.
  • To investigate the role of specific Campylobacter species and HLA-B27 in ReA development.

Main Methods:

  • A population-based study involving questionnaires and clinical examinations.

Related Experiment Videos

  • 870 patients with Campylobacter-positive stool cultures and 1440 matched controls were surveyed for enteric and musculoskeletal symptoms.
  • Analysis focused on self-reported symptoms and clinical findings.

    • Main Results:

    • The annual incidence of ReA was 4.3 per 100,000 population.
    • 7% of Campylobacter patients developed ReA, and 1% experienced other reactive musculoskeletal conditions.
    • ReA was more common in adults, typically mild and oligo- or polyarticular, and not associated with HLA-B27. Both Campylobacter jejuni and Campylobacter coli were identified as triggers.

    Conclusions:

    • Reactive arthritis is a frequent complication of Campylobacter infection, with significant population-level impact.
    • The study highlights that Campylobacter coli, similar to Campylobacter jejuni, can precipitate ReA.
    • Clinical presentation of acute ReA in the population is generally mild and predominantly affects adults.